MCID: BLT006
MIFTS: 45

Bilateral Breast Cancer

Categories: Cancer diseases

Aliases & Classifications for Bilateral Breast Cancer

MalaCards integrated aliases for Bilateral Breast Cancer:

Name: Bilateral Breast Cancer 12 55 15 72
Bilateral Breast Carcinoma 12 6

Classifications:



External Ids:

Disease Ontology 12 DOID:6741
NCIt 50 C8287
UMLS 72 C0281267

Summaries for Bilateral Breast Cancer

Disease Ontology : 12 A breast carcinoma that is characterized by an individual having breast cancer in both breasts, either simultaneously or at different times.

MalaCards based summary : Bilateral Breast Cancer, also known as bilateral breast carcinoma, is related to ataxia-telangiectasia and li-fraumeni syndrome. An important gene associated with Bilateral Breast Cancer is BRCA1 (BRCA1 DNA Repair Associated), and among its related pathways/superpathways are Gene Expression and Cell Cycle, Mitotic. The drugs Sargramostim and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include breast, lymph node and testes, and related phenotypes are Decreased viability and Decreased viability

Related Diseases for Bilateral Breast Cancer

Diseases related to Bilateral Breast Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 225, show less)
# Related Disease Score Top Affiliating Genes
1 ataxia-telangiectasia 30.3 CHEK2 BRCA1 ATM
2 li-fraumeni syndrome 30.0 CHEK2 BRCA2 BRCA1 ATM
3 comedo carcinoma 29.8 ESR1 ERBB2
4 lobular neoplasia 29.7 ESR1 ERBB2 BRCA1
5 papillary serous adenocarcinoma 29.7 PGR BRCA1
6 estrogen excess 29.4 PGR ESR1
7 gynecomastia 29.2 PGR ESR1
8 hereditary breast ovarian cancer syndrome 29.0 RAD51 CHEK2 BRCA2 BRCA1 ATM
9 in situ carcinoma 29.0 PGR ESR1 ERBB2 BRCA1
10 cervical adenocarcinoma 28.9 PGR ESR1 ERBB2
11 mammary paget's disease 28.7 PGR ESR1 ERBB2
12 tubular adenocarcinoma 28.7 PGR ESR1 ERBB2
13 breast fibroadenoma 28.7 PGR ESR1 ERBB2
14 endometrial adenocarcinoma 28.7 PGR ESR1 ERBB2
15 prostate cancer 28.5 ESR1 ERBB2 CHEK2 BRCA2 BRCA1
16 adenoid cystic carcinoma 28.3 PGR ERBB2 CHEK2 ATM
17 synchronous bilateral breast carcinoma 28.3 PGR ESR1 BRCA2 BRCA1 ATM
18 ductal carcinoma in situ 28.3 PGR ESR1 ERBB2 BRCA2 BRCA1
19 breast ductal carcinoma 28.2 PGR ESR1 ERBB2 BRCA1
20 breast disease 28.2 PGR ESR1 ERBB2 BRCA2 BRCA1
21 endometrial cancer 27.8 PGR ESR1 ERBB2 BRCA2 BRCA1
22 female breast cancer 27.7 PGR ESR1 ERBB2 BRCA2 BRCA1 ATM
23 ovarian cancer 27.0 PGR ESR1 ERBB2 CHEK2 BRCA2 BRCA1
24 breast cancer 26.9 RAD51 PGR FHIT ESR1 ERBB2 CHEK2
25 sporadic breast cancer 25.3 RAD51 PGR FHIT ESR1 ERBB2 CHEK2
26 hereditary site-specific ovarian cancer syndrome 10.6 BRCA2 BRCA1
27 breast-ovarian cancer, familial 1 10.5 BRCA2 BRCA1
28 pancreatic neuroendocrine tumor 10.5 BRCA2 ATM
29 peritoneum cancer 10.5 BRCA2 BRCA1
30 premature menopause 10.5 BRCA2 BRCA1
31 fallopian tube disease 10.5 BRCA2 BRCA1
32 fanconi anemia, complementation group u 10.4 RAD51 BRCA1
33 mutagen sensitivity 10.4 BRCA2 BRCA1
34 clivus chordoma 10.3 CHEK2 ATM
35 lynch syndrome i 10.3 BRCA2 BRCA1
36 fanconi anemia, complementation group d2 10.3 RAD51 BRCA2
37 breast giant fibroadenoma 10.3 ESR1 BRCA2
38 fanconi anemia, complementation group v 10.3 RAD51 BRCA1
39 uterine corpus serous adenocarcinoma 10.3 ERBB2 BRCA1
40 fanconi anemia, complementation group r 10.2 RAD51 BRCA1
41 fanconi anemia, complementation group q 10.2 RAD51 BRCA2 BRCA1
42 nijmegen breakage syndrome 10.1 CHEK2 BRCA1 ATM
43 fanconi anemia, complementation group t 10.1 RAD51 BRCA1
44 peutz-jeghers syndrome 10.1
45 li-fraumeni syndrome 2 10.1
46 t-cell prolymphocytic leukemia 10.1 CHEK2 ATM
47 congenital hypoplastic anemia 10.1 RAD51 BRCA2
48 infant gynecomastia 10.1
49 tuberculous salpingitis 10.0 ERBB2 BRCA2 BRCA1
50 fallopian tube adenocarcinoma 10.0 ERBB2 BRCA2 BRCA1
51 telangiectasis 10.0
52 dysphagia 10.0
53 ovarian cancer 1 10.0 ERBB2 BRCA2 BRCA1
54 hidradenocarcinoma 10.0 ESR1 ERBB2
55 corneal abscess 9.9 RAD51 PGR
56 bartholin's gland adenoma 9.9 PGR ESR1
57 vestibular gland benign neoplasm 9.9 PGR ESR1
58 lung leiomyoma 9.9 PGR ESR1
59 vulvar syringoma 9.9 PGR ESR1
60 vulvar leiomyoma 9.9 PGR ESR1
61 trigonitis 9.9 PGR ESR1
62 vulvar benign neoplasm 9.9 PGR ESR1
63 predominantly cortical thymoma 9.9 PGR ESR1
64 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.9
65 osteogenic sarcoma 9.9
66 ataxia and polyneuropathy, adult-onset 9.9
67 body mass index quantitative trait locus 1 9.9
68 hypogonadotropic hypogonadism 9.9
69 neutropenia 9.9
70 cowden syndrome 9.9
71 oncocytic breast carcinoma 9.9 PGR ESR1
72 bartholin's gland benign neoplasm 9.9 PGR ESR1
73 cribriform carcinoma 9.9 PGR ESR1
74 endometrial squamous cell carcinoma 9.9 PGR ESR1
75 progesterone resistance 9.9 PGR ESR1
76 adenoid basal cell carcinoma 9.9 PGR ESR1
77 endometrial mucinous adenocarcinoma 9.9 PGR ESR1
78 diffuse peritoneal leiomyomatosis 9.9 PGR ESR1
79 leiomyomatosis 9.9 PGR ESR1
80 deep angioma 9.9 PGR ESR1
81 gender identity disorder 9.9 PGR ESR1
82 peritoneal benign neoplasm 9.9 PGR ESR1
83 cervical carcinosarcoma 9.9 PGR ESR1
84 female reproductive endometrioid cancer 9.9 PGR ESR1
85 intramuscular hemangioma 9.9 PGR ESR1
86 cervical clear cell adenocarcinoma 9.9 PGR ESR1
87 mammographic density 9.8 PGR ESR1
88 breast apocrine carcinoma 9.8 PGR ERBB2
89 retinitis pigmentosa 47 9.8 PGR ESR1
90 scirrhous adenocarcinoma 9.8 PGR ERBB2
91 cancerophobia 9.8 PGR BRCA2 BRCA1
92 nosophobia 9.8 PGR BRCA2 BRCA1
93 adenosarcoma 9.8 PGR ESR1
94 intracystic papillary adenoma 9.8 PGR ERBB2
95 retinitis pigmentosa 20 9.8 PGR ESR1
96 breast metaplastic carcinoma 9.8 PGR ERBB2
97 progesterone-receptor negative breast cancer 9.8 PGR ERBB2
98 dysgerminoma of ovary 9.8 PGR BRCA2 BRCA1
99 endometriosis of ovary 9.8 PGR ESR1
100 uterine body mixed cancer 9.8 PGR ERBB2
101 smooth muscle tumor 9.8 PGR ESR1
102 pheochromocytoma 9.8
103 multiple endocrine neoplasia, type iia 9.8
104 lymphoma, hodgkin, classic 9.8
105 lymphoma, non-hodgkin, familial 9.8
106 aplastic anemia 9.8
107 myxoid liposarcoma 9.8
108 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.8
109 diffuse large b-cell lymphoma 9.8
110 adrenal gland pheochromocytoma 9.8
111 leiomyosarcoma 9.8
112 hemoglobinopathy 9.8
113 papillary carcinoma 9.8
114 liver disease 9.8
115 collecting duct carcinoma 9.8
116 breast liposarcoma 9.8
117 b-cell lymphoma 9.8
118 48,xyyy 9.8
119 thyroid carcinoma 9.8
120 fanconi anemia, complementation group a 9.8 RAD51 BRCA2 BRCA1 ATM
121 microglandular adenosis 9.8 PGR ERBB2
122 hepatocellular carcinoma 9.8
123 systemic lupus erythematosus 9.8
124 acrofacial dysostosis 1, nager type 9.8
125 mirror movements 1 9.8
126 neurofibromatosis, type iv, of riccardi 9.8
127 kindler syndrome 9.8
128 pancreatic cancer 9.8
129 pituitary adenoma, prolactin-secreting 9.8
130 asthma 9.8
131 cervical cancer 9.8
132 gastrointestinal stromal tumor 9.8
133 ewing sarcoma 9.8
134 leukemia, acute lymphoblastic 9.8
135 gastric cancer 9.8
136 congenital short bowel syndrome 9.8
137 hyperprolactinemia 9.8
138 angiosarcoma 9.8
139 follicular lymphoma 9.8
140 crest syndrome 9.8
141 myxofibrosarcoma 9.8
142 osteonecrosis 9.8
143 dermatomyositis 9.8
144 lymphocytic leukemia 9.8
145 sarcoma 9.8
146 goiter 9.8
147 graves' disease 9.8
148 urticaria 9.8
149 diffuse scleroderma 9.8
150 squamous cell carcinoma 9.8
151 vascular disease 9.8
152 thyroid gland cancer 9.8
153 calcinosis 9.8
154 hypogonadism 9.8
155 dermatitis 9.8
156 adenocarcinoma 9.8
157 mucinous adenocarcinoma 9.8
158 serous cystadenocarcinoma 9.8
159 neurilemmoma 9.8
160 liposarcoma 9.8
161 histiocytosis 9.8
162 cellulitis 9.8
163 appendix adenocarcinoma 9.8
164 plexopathy 9.8
165 systemic scleroderma 9.8
166 spindle cell sarcoma 9.8
167 carcinosarcoma 9.8
168 thyroiditis 9.8
169 hypogonadotropism 9.8
170 situs inversus 9.8
171 hyperthyroidism 9.8
172 peritonitis 9.8
173 intestinal obstruction 9.8
174 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.8
175 lupus erythematosus 9.8
176 pulmonary embolism 9.8
177 bronchiectasis 9.8
178 keloid disorder 9.8
179 ovarian sex cord tumor with annular tubules 9.8
180 radiation induced cancer 9.8
181 raynaud phenomenon 9.8
182 paraneoplastic syndromes 9.8
183 pituitary tumors 9.8
184 uterine benign neoplasm 9.8 PGR ESR1
185 prostatic hypertrophy 9.7 PGR ESR1
186 endometritis 9.7 PGR ESR1
187 barrett's adenocarcinoma 9.7 RAD51 FHIT ERBB2
188 breast secretory carcinoma 9.7 PGR ERBB2
189 reproductive organ benign neoplasm 9.7 PGR ESR1
190 mixed cell type cancer 9.7 PGR ERBB2
191 juvenile nasopharyngeal angiofibroma 9.7 PGR ESR1
192 papillary adenocarcinoma 9.5 PGR ERBB2
193 gonadal disease 9.5 ESR1 ERBB2 BRCA2 BRCA1
194 endocrine gland cancer 9.5 ESR1 ERBB2 BRCA2 BRCA1
195 angiomyolipoma 9.5 PGR ESR1
196 glassy cell carcinoma of the cervix 9.4 PGR ESR1 ERBB2
197 breast scirrhous carcinoma 9.4 PGR ESR1 ERBB2
198 progesterone-receptor positive breast cancer 9.4 PGR ESR1 ERBB2
199 apocrine adenocarcinoma 9.4 PGR ESR1 ERBB2
200 breast adenoid cystic carcinoma 9.4 PGR ESR1 ERBB2
201 inflammatory breast carcinoma 9.4 PGR ESR1 ERBB2
202 luminal breast carcinoma 9.4 PGR ESR1 ERBB2
203 thoracic benign neoplasm 9.4 PGR ESR1 ERBB2
204 breast benign neoplasm 9.4 PGR ESR1 ERBB2
205 lipid-rich carcinoma 9.4 PGR ESR1 ERBB2
206 estrogen-receptor positive breast cancer 9.4 PGR ESR1 ERBB2
207 sweat gland cancer 9.4 PGR ESR1 ERBB2
208 glycogen-rich clear cell breast carcinoma 9.3 PGR ESR1 BRCA2 BRCA1
209 uterine anomalies 9.3 PGR ESR1 ERBB2
210 ovarian disease 9.3 PGR ESR1 BRCA2 BRCA1
211 esophageal cancer 9.3 RAD51 FHIT ERBB2 CHEK2
212 primary peritoneal carcinoma 9.3 PGR ERBB2 BRCA2 BRCA1
213 leiomyoma, uterine 9.2 PGR ESR1
214 breast medullary carcinoma 9.1 PGR ESR1 ERBB2 BRCA1
215 uterine corpus cancer 9.1 PGR ESR1 ERBB2 BRCA1
216 estrogen-receptor negative breast cancer 9.1 PGR ESR1 ERBB2 BRCA1
217 pre-malignant neoplasm 8.8 PGR ESR1 ERBB2 BRCA2 BRCA1
218 fallopian tube carcinoma 8.8 PGR ESR1 ERBB2 BRCA2 BRCA1
219 breast carcinoma in situ 8.8 PGR ESR1 ERBB2 BRCA2 BRCA1
220 ovary epithelial cancer 8.8 PGR ESR1 ERBB2 BRCA2 BRCA1
221 malignant ovarian surface epithelial-stromal neoplasm 8.8 PGR ESR1 ERBB2 BRCA2 BRCA1
222 female reproductive system disease 8.8 PGR ESR1 ERBB2 BRCA2 BRCA1
223 reproductive system disease 8.8 PGR ESR1 ERBB2 BRCA2 BRCA1
224 wilms tumor 1 8.7 PGR ESR1 ERBB2 CHEK2 BRCA2
225 adamantinoma of long bones 8.3 PGR FHIT ESR1 ERBB2 BRCA2 BRCA1

Graphical network of the top 20 diseases related to Bilateral Breast Cancer:



Diseases related to Bilateral Breast Cancer

Symptoms & Phenotypes for Bilateral Breast Cancer

GenomeRNAi Phenotypes related to Bilateral Breast Cancer according to GeneCards Suite gene sharing:

26 (showing 17, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00221-A-1 10.58 ESR1
2 Decreased viability GR00221-A-2 10.58 CHEK2 ESR1 BRCA1
3 Decreased viability GR00221-A-3 10.58 ATM CHEK2 ERBB2 BRCA1
4 Decreased viability GR00221-A-4 10.58 ATM CHEK2 ERBB2 ESR1
5 Decreased viability GR00301-A 10.58 BRCA1
6 Decreased viability GR00342-S-2 10.58 CHEK2
7 Decreased viability GR00402-S-2 10.58 ATM CHEK2 ERBB2 ESR1 BRCA1
8 Decreased homologous recombination repair frequency GR00151-A-1 10.28 BRCA1 RAD51
9 Decreased homologous recombination repair frequency GR00151-A-2 10.28 BRCA1 RAD51
10 Decreased homologous recombination repair frequency GR00236-A-3 10.28 BRCA1 BRCA2 RAD51
11 Decreased viability in esophageal squamous lineage GR00235-A 9.87 BRCA1 BRCA2 CHEK2 ERBB2 ESR1 PGR
12 Increased viability with MLN4924 (a NAE inhibitor) GR00250-A-3 9.55 ATM BRCA1 BRCA2 CHEK2 RAD51
13 Decreased viability after ionizing radiation GR00232-A-2 9.54 ATM BRCA1 BRCA2
14 Decreased viability with cisplatin GR00101-A-4 9.43 BRCA1 BRCA2 RAD51
15 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.28 ATM BRCA1 BRCA2 CHEK2
16 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.28 ATM BRCA1 BRCA2 CHEK2 RAD51
17 Synthetic lethal with cisplatin GR00101-A-1 9.13 BRCA1 BRCA2 RAD51

MGI Mouse Phenotypes related to Bilateral Breast Cancer:

46 (showing 12, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.11 ATM BRCA1 BRCA2 CHEK2 ERBB2 ESR1
2 embryo MP:0005380 10.02 ATM BRCA1 BRCA2 ERBB2 ESR1 PGR
3 homeostasis/metabolism MP:0005376 10.01 ATM BRCA1 BRCA2 CHEK2 ERBB2 ESR1
4 endocrine/exocrine gland MP:0005379 10 ATM BRCA1 BRCA2 CHEK2 ERBB2 ESR1
5 hematopoietic system MP:0005397 9.98 ATM BRCA1 BRCA2 CHEK2 ESR1 FHIT
6 immune system MP:0005387 9.91 ATM BRCA1 BRCA2 CHEK2 ESR1 FHIT
7 digestive/alimentary MP:0005381 9.89 BRCA1 BRCA2 ERBB2 ESR1 FHIT
8 integument MP:0010771 9.87 ATM BRCA1 BRCA2 ERBB2 ESR1 FHIT
9 mortality/aging MP:0010768 9.81 ATM BRCA1 BRCA2 CHEK2 ERBB2 ESR1
10 limbs/digits/tail MP:0005371 9.65 BRCA1 BRCA2 ERBB2 ESR1 PGR
11 neoplasm MP:0002006 9.56 ATM BRCA1 BRCA2 CHEK2 ERBB2 ESR1
12 reproductive system MP:0005389 9.1 ATM BRCA1 BRCA2 ERBB2 ESR1 PGR

Drugs & Therapeutics for Bilateral Breast Cancer

Drugs for Bilateral Breast Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 40, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sargramostim Approved, Investigational Phase 2 83869-56-1, 123774-72-1
2
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
3
leucovorin Approved Phase 2 58-05-9 143 6006
4
Sulindac Approved, Investigational Phase 2 38194-50-2 5352 1548887
5
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
6
Emodepside Investigational, Vet_approved Phase 2 155030-63-0
7 Alkylating Agents Phase 2
8 Micronutrients Phase 2
9 Trace Elements Phase 2
10 Vaccines Phase 2
11 Immunologic Factors Phase 2
12 Vitamins Phase 2
13 Vitamin B Complex Phase 2
14 Vitamin B9 Phase 2
15 Hematinics Phase 2
16 Immunosuppressive Agents Phase 2
17 Folate Phase 2
18 Nutrients Phase 2
19 Antineoplastic Agents, Alkylating Phase 2
20 Tubulin Modulators Phase 2
21 Epothilone B Phase 2
22 Epothilones Phase 2
23 Antimitotic Agents Phase 2
24 Estrogens Phase 2
25 Hormones Phase 2
26 Hormone Antagonists Phase 2
27 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
28 Antirheumatic Agents Phase 2
29 Analgesics Phase 2
30 Cyclooxygenase Inhibitors Phase 2
31 Anti-Inflammatory Agents, Non-Steroidal Phase 2
32 Steroid Synthesis Inhibitors Phase 2
33 Peripheral Nervous System Agents Phase 2
34 Analgesics, Non-Narcotic Phase 2
35 Anti-Inflammatory Agents Phase 2
36 Estrogen Receptor Antagonists Phase 2
37 Estrogen Antagonists Phase 2
38 Aromatase Inhibitors Phase 2
39
Progesterone Approved, Vet_approved Phase 1 57-83-0 5994
40 Progestins Phase 1

Interventional clinical trials:

(showing 8, show less)
# Name Status NCT ID Phase Drugs
1 Double Blind, Parallel Groups, Controlled, Randomized Phase II Trial to Evaluate Vaccination With Folate Receptor Alpha Peptide Vaccine With GM-CSF as Vaccine Adjuvant Following Oral Cyclophosphamide Versus GM-CSF/Placebo to Prevent Recurrence in Patients With Triple Negative Breast Cancer Recruiting NCT03012100 Phase 2 Cyclophosphamide
2 A Phase II Randomized Study of Ixabepilone vs. Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2/Neu-Negative Breast Cancer Active, not recruiting NCT00877500 Phase 2 Ixabepilone
3 NSAID Effects on Clinical and Imaging Breast Biomarkers Active, not recruiting NCT01761877 Phase 2 Sulindac
4 A Phase 1b Study of M6620 in Combination With Radiation Therapy to Overcome Therapeutic Resistance in Chemotherapy Resistant Triple Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer Not yet recruiting NCT04052555 Phase 1 ATR Kinase Inhibitor M6620
5 Genetic Counseling for Breast Cancer Survivors (GC for BC) Completed NCT02451735
6 Longitudinal Observational Study About the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer Completed NCT03669952
7 Establishment of Normal High Risk Breast Epithelial Cell Cultures, and A High Risk Cell Line and Tissue Repository From Breast Tissue From Women at High Risk of Breast Cancer Completed NCT00032201
8 Genome-Wide Association Study of Radiation Exposure and Bilateral Breast Cancer Active, not recruiting NCT00903591

Search NIH Clinical Center for Bilateral Breast Cancer

Genetic Tests for Bilateral Breast Cancer

Anatomical Context for Bilateral Breast Cancer

MalaCards organs/tissues related to Bilateral Breast Cancer:

41
Breast, Lymph Node, Testes, Prostate, Skin, Ovary, Lung

Publications for Bilateral Breast Cancer

Articles related to Bilateral Breast Cancer:

(showing 814, show less)
# Title Authors PMID Year
1
A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer. 9 38
19649703 2010
2
A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family. 9 38
19288190 2010
3
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. 9 38
20104584 2010
4
Robotic resection of intraductal neoplasm of the pancreas. 9 38
19698031 2009
5
A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region. 9 38
19393826 2009
6
Age at onset of bilateral breast cancer, the presence of hereditary BRCA1, BRCA2, CHEK2 gene mutations and positive family history of cancer. 9 38
19372713 2009
7
Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. 9 38
19153073 2009
8
Accuracy of the BRCAPRO model among women with bilateral breast cancer. 9 38
19127556 2009
9
Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer. 9 38
19629752 2009
10
Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer. 9 38
18264724 2008
11
Altered DNA binding by the human Rad51-R150Q mutant found in breast cancer patients. 9 38
17666788 2007
12
[Analysis of the mutation of BRCA1 gene in 70 Uigur women breast cancer patients in Xinjiang]. 9 38
17557253 2007
13
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. 9 38
16331614 2006
14
Association of common ATM polymorphism with bilateral breast cancer. 9 38
15756685 2005
15
A comparison of bilateral breast cancers in BRCA carriers. 9 38
15941968 2005
16
BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. 9 38
15319244 2004
17
ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. 9 38
14562025 2003
18
Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. 9 38
12673797 2003
19
Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer. 9 38
12151349 2002
20
BRCA1 and BRCA2 mutations in Russian familial breast cancer. 9 38
11793480 2002
21
Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing. 9 38
11802208 2002
22
Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. 9 38
11556836 2001
23
BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. 9 38
11389159 2001
24
Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. 9 38
11149425 2001
25
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. 9 38
11130383 2000
26
Frequency of germ-line BRCA1 mutations among Spanish families from a Mediterranean area. 9 38
10737987 2000
27
Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure. 9 38
10699917 2000
28
Identification of Rad51 alteration in patients with bilateral breast cancer. 9 38
10807537 2000
29
BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer. 9 38
10573018 1999
30
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2. 9 38
10188893 1999
31
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. 9 38
9333265 1997
32
Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. 9 38
9157994 1997
33
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. 9 38
9145677 1997
34
Germline mutation of BRCA1 in Japanese breast cancer families. 9 38
7627958 1995
35
Estrogen and progesterone receptor content in bilateral breast cancer. 9 38
7651928 1995
36
Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. 9 38
8281142 1993
37
Bilateral breast cancer: one disease or two? 9 38
1663803 1991
38
Bilateral erector spinae nerve block using one injection for bilateral breast cancer surgery. 38
30776776 2019
39
High relative levels of satellite alpha transcripts predict increased risk of bilateral breast cancer and multiple primary cancer in patients with breast cancer and lacking BRCA‑related clinical features. 38
31173247 2019
40
From uncertainty to pathogenicity: clinical and functional interrogation of a rare TP53 in-frame deletion. 38
30886117 2019
41
The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients. 38
31368036 2019
42
Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan. 38
30309218 2019
43
Synchronous and Metachronous bilateral breast Cancer: Clinicopathologic characteristics and prognostic outcomes. 38
31351153 2019
44
National trends of synchronous bilateral breast cancer incidence in the United States. 38
31325072 2019
45
Pseudo skin flash on VMAT in breast radiotherapy: Optimization of virtual bolus thickness and HU values. 38
31221409 2019
46
Local Tumor Staging of Breast Cancer: Digital Mammography versus Digital Mammography Plus Tomosynthesis. 38
30964425 2019
47
Differential Profile of BRCA1 vs. BRCA2 Mutated Families: A Characterization of the Main Differences and Similarities in Patients. 38
31244284 2019
48
The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018). 38
31038845 2019
49
Does race predict survival for women with invasive breast cancer? 38
31206623 2019
50
Tamoxifen related Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A case report and literature review of this possible association. 38
30799070 2019
51
Chemotherapy-induced posterior reversible encephalopathy syndrome: Three case reports. 38
31083272 2019
52
Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer. 38
31119730 2019
53
Does the subtype of breast cancer affect the diagnostic performance of axillary ultrasound for nodal staging in breast cancer patients? 38
30732971 2019
54
Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiation. 38
30935400 2019
55
A rare case of cancer-to-cancer metastasis: breast cancer to renal cell cancer : Case report and review of literature. 38
31041627 2019
56
Breast cancer mortality in synchronous bilateral breast cancer patients. 38
30804429 2019
57
Skin and lung toxicity in synchronous bilateral breast cancer treated with volumetric-modulated arc radiotherapy: a mono-institutional experience. 38
30875061 2019
58
Whole Exome Sequencing in the Accurate Diagnosis of Bilateral Breast Cancer: a Case Study. 38
30941240 2019
59
Metachronous bilateral triple-negative breast cancer associated with neurofibromatosis type 1: A case report. 38
30854057 2019
60
[A Case of Synchronous Bilateral Breast Cancer in an Elderly Patient]. 38
30914557 2019
61
[Locoregional control and patterns of locoregional failure in women with breast cancer treated by highly conformal electron beam irradiation]. 38
30595340 2019
62
Esophageal metastasis of breast cancer during endocrine therapy for pleural dissemination 21 years after breast surgery: a case report. 38
30771195 2019
63
When breast cancer gets complicated. A case report of synchronous bilateral breast cancers with discordant tumor markers from the primary to nodes with findings of a sentinel internal mammary subpectoral lymph node. 38
30788096 2019
64
Results of a nationwide survey on Japanese clinical practice in breast-conserving radiotherapy for breast cancer. 38
30476198 2019
65
The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans. 38
30622657 2019
66
Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk? 38
30165125 2019
67
Endometrial Endometrioid Carcinoma With Ovarian Metastasis Showing Morula-like Features in a Patient With Cowden Syndrome: A Case Report. 38
30676432 2019
68
Body mass index and diabetes are important prognostic signatures for bilateral breast cancer prognosis. 38
30618092 2019
69
New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer. 38
30553462 2018
70
Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families. 38
29988077 2018
71
Surgical treatment of early stage breast cancer in the Auckland and Waikato regions of New Zealand. 38
30253442 2018
72
Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography. 38
30396659 2018
73
The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations. 38
30014164 2018
74
Synchronous and metachronous bilateral breast cancer: A long-term experience. 38
30610782 2018
75
[Clinicopathologic and molecular characteristics of synchronous bilateral breast cancer]. 38
30317747 2018
76
Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours. 38
30141242 2018
77
Clinico-pathological characteristics and treatment outcome in invasive lobular carcinoma of the breast: An Indian experience. 38
30829268 2018
78
Clinical and Pathologic Features of Clinically Occult Synchronous Bilateral Breast Cancers. 38
28935459 2018
79
Brevibacterium casei bacteraemia in a port-a-cath carrier patient: a case report. 38
30246770 2018
80
Surgeon Variability and Factors Predicting for Reoperation Following Breast-Conserving Surgery. 38
29786129 2018
81
Synchronous bilateral breast cancer patients submitted to conservative treatment and brachytherapy - The experience of a service. 38
30127671 2018
82
Including internal mammary lymph nodes in radiation therapy for synchronous bilateral breast cancer: an international survey of treatment technique and clinical priorities. 38
29869775 2018
83
Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population. 38
29254601 2018
84
Sequential Sentinel Node Scintigraphy With Planar and SPECT/CT Images Revealed Contralateral Drainage From Ipsilateral Breast Tumor Relapse in a Patient With Bilateral Breast Cancer. 38
29659396 2018
85
Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature. 38
29475749 2018
86
68Ga-Prostate-Specific Membrane Antigen PET/CT in Triple-Negative Breast Cancer. 38
29578872 2018
87
Radiation therapy of synchronous bilateral breast carcinoma (SBBC) using multiple techniques. 38
28988893 2018
88
Bilateral Metachronous Breast Carcinoma: A Rare Case Report. 38
29744328 2018
89
Incidence and tumour characteristics of bilateral and unilateral interval breast cancers at screening mammography. 38
29306176 2018
90
Breast Cancer is Common in Women With Ovarian Malignant Mixed Mullerian Tumors. 38
26757435 2018
91
Characterization of mutations in BRCA1/2 and the relationship with clinic-pathological features of breast cancer in a hereditarily high-risk sample of chinese population. 38
29435039 2018
92
Germline breast cancer susceptibility gene mutations and breast cancer outcomes. 38
29566657 2018
93
Increasing survival of metastatic breast cancer through locoregional surgery. 38
28994557 2018
94
Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer. 38
29315233 2018
95
Synchronous bilateral breast cancer: A case report of heterogeneous estrogen receptor status. 38
30391732 2018
96
Favorable progression-free survival in women with two different histopathological subtypes of bilateral breast cancer. 38
30589050 2018
97
Next generation sequencing is informing phenotype: a TP53 example. 38
28509937 2018
98
Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family. 38
29346284 2018
99
Bilateral synchronous breast cancer developed as metachronous malignancy after therapy of other primaries. 38
30084474 2018
100
Treatment of axillary web syndrome using instrument assisted soft tissue mobilization and thoracic manipulation for associated thoracic rotation dysfunction. 38
28854081 2018
101
Pre-operative Axillary Ultrasound-Guided Needle Sampling in Breast Cancer: Comparing the Sensitivity of Fine Needle Aspiration Cytology and Core Needle Biopsy. 38
29063297 2018
102
The robustness of dual isocenter VMAT radiation therapy for bilateral lymph node positive breast cancer. 38
29254586 2017
103
Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery. 38
28976793 2017
104
Treatment of bilateral breast cancer and regional nodes using an opposed lateral beam arrangement. 38
28867548 2017
105
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. 38
28477318 2017
106
Bilateral Breast Cancer with Neurofibromatosis Type 1 Patient: Case Report. 38
29082380 2017
107
The role of BRCA status on prognosis in patients with triple-negative breast cancer. 38
29152070 2017
108
Breast cancer metastases to the thyroid gland - an uncommon sentinel for diffuse metastatic disease: a case report and review of the literature. 38
28934992 2017
109
Comparison of Helical Tomotherapy and Direct Tomotherapy in Bilateral Whole Breast Irradiation in a Case of Bilateral Synchronous Grade 1 and Stage 1 Breast Cancer. 38
28935854 2017
110
Radiologic manifestation of the malignant peripheral nerve sheet tumor involving the brachial plexus. 38
28828137 2017
111
First clinical report of helical tomotherapy with simultaneous integrated boost for synchronous bilateral breast cancer. 38
28707988 2017
112
Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer. 38
28423363 2017
113
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial. 38
28592386 2017
114
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. 38
28281021 2017
115
Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost. 38
28224401 2017
116
Synchronous Bilateral Breast Cancer in a Patient With Nager Syndrome. 38
28139434 2017
117
The Role of Genetic Testing in Patients With Breast Cancer: A Review. 38
28423155 2017
118
Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers. 38
28730766 2017
119
Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts. 38
27541026 2017
120
Synchronous Bilateral Breast Cancer With Discordant Histology. 38
28412779 2017
121
pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trials. 38
28063331 2017
122
PALB2 mutation in a woman with bilateral breast cancer: A case report. 38
28413668 2017
123
Refractory Tamoxifen-Induced Keratopathy Despite Drug Withdrawal. 38
27918356 2017
124
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families. 38
27025497 2017
125
First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report. 38
28184945 2017
126
Synchronous and bilateral oncocytic carcinoma of the breast: A case report and review of the literature. 38
28454314 2017
127
Gastric metastasis of bilateral breast cancer. 38
28280631 2017
128
Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway. 38
28241424 2017
129
Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis. 38
28770017 2017
130
The Preventive Intervention of Hereditary Breast Cancer. 38
29282679 2017
131
Bilateral Breast Cancer After Prophylactic Bilateral Pulmonary Irradiation. 38
28272005 2017
132
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan. 38
27826754 2017
133
Totally implantable venous access port via the femoral vein in a femoral port position with CT-venography. 38
27658579 2016
134
Bilateral Breast Irradiation Using Hybrid Volumetric Modulated Arc Therapy (h-VMAT) Technique: A Planning Case Report. 38
28083458 2016
135
Simultaneous integrated bilateral breast and nodal irradiation with volumetric arc therapy: case report and literature review. 38
27716877 2016
136
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer. 38
26467036 2016
137
Co-existence of a giant cell tumour of the tendon sheath and schwannoma in a patient with bilateral breast cancer: A potential cause of false positive findings in 18F-FDG PET/CT studies. 38
27329560 2016
138
[Right Hemi-Colectomy for a Metastatic Transverse Colon Tumor from Breast Cancer Following Bilateral Breast Cancer Resection - A Case Report]. 38
28133217 2016
139
Bilateral breast cancer resection performed under the bilateral transversus thoracic muscle plane block. 38
27555202 2016
140
The effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorder. 38
27542210 2016
141
Evaluation of Clinicopathological Findings on 255 cases of Inoperable Locally Advanced Breast Carcinoma: A Tertiary Care Experience. 38
28191801 2016
142
Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033). 38
27650678 2016
143
Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. 38
27345635 2016
144
Helical tomotherapy for bilateral breast cancer: Clinical experience. 38
27253152 2016
145
Challenges of treating incidental synchronous bilateral breast cancer with differing tumour biology. 38
27539136 2016
146
Incidental unilateral and bilateral ductal carcinoma in situ encountered in the surgical management of young male gynecomastia. 38
27612041 2016
147
Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR. 38
27307436 2016
148
Relevance of intraoperative indocyanine green injection in breast reconstruction using DIEP procedure for abdominal scars. 38
27066700 2016
149
KOHBRA BRCA risk calculator (KOHCal): a model for predicting BRCA1 and BRCA2 mutations in Korean breast cancer patients. 38
26763880 2016
150
BILATERAL BREAST CANCER: DIAGNOSIS AND PROGNOSIS. 38
27483711 2016
151
The risk of contralateral breast cancer in daughters of women with and without breast cancer. 38
25920602 2016
152
[Relationship of clinicopathological features and chemotherapeutic outcomes in women with BRCA1 and BRCA2 mutation-negative familial breast cancer]. 38
26988823 2016
153
Autoantibodies directed to centromere protein F in a patient with BRCA1 gene mutation. 38
26868636 2016
154
[Synchronous bilateral breast cancer and pregnancy: about 3 cases at Joliot Curie institute of Dakar (Senegal)]. 38
27279967 2016
155
[Synchronous bilateral breast cancer: experiences in the Mohammed VI Cancer Treatment Center, CHU Ibn Rochd, Casablanca]. 38
28292084 2016
156
Long-term effects of first degree family history of breast cancer in young women: Recurrences and bilateral breast cancer. 38
26399280 2016
157
Image-guided intensity-modulated radiotherapy for refractory bilateral breast cancer in a patient with extensive cutaneous metastasis in the chest and abdominal walls. 38
27284253 2016
158
Femoral Placement of Totally Implantable Venous Access Ports in Patients with Bilateral Breast Cancer. 38
26855441 2016
159
Unilateral Arm Urticaria Presenting as a Paraneoplastic Manifestation of Metachronous Bilateral Breast Cancer. 38
26933416 2016
160
Disease evolution and heterogeneity in bilateral breast cancer. 38
27904775 2016
161
EVOLUTION OF SYNCHRONOUS BILATERAL BREAST CARCINOMA IN A YOUNG PATIENT. 38
27125095 2016
162
Is helical tomotherapy-based intensity-modulated radiotherapy feasible and effective in bilateral synchronous breast cancer? A two-center experience. 38
27061530 2016
163
Innovative combination of therapeutic mammoplasty and expandable-implant breast augmentation for immediate partial breast reconstruction. 38
27132043 2016
164
Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore. 38
29263802 2016
165
Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes. 38
26770289 2016
166
Breast Sclerosing Adenosis and Accompanying Malignancies: A Clinicopathological and Imaging Study in a Chinese Population. 38
26656378 2015
167
Ewing Sarcoma in a Patient With Cowden Syndrome. 38
26553762 2015
168
Goldilocks mastectomy for obese Japanese females with breast ptosis. 38
23972507 2015
169
Breast-Conserving Surgery in Bilateral Breast Cancer. 38
26265365 2015
170
Comparative genomic analysis reveals bilateral breast cancers are genetically independent. 38
26378809 2015
171
Synchronous Bilateral Breast Cancers. 38
26500995 2015
172
Volumetric modulated arc therapy for synchronous bilateral whole breast irradiation - A case study. 38
26549999 2015
173
Multifocal Bilateral Breast Cancer and Breast Follicular Lymphoma: A Simple Coincidence? 38
26472982 2015
174
Bilateral breast cancer with a unilateral carcinoma within a fibroadenoma: A case report. 38
26622700 2015
175
Bilateral breast cancer, synchronous and metachronous; differences and outcome. 38
26268697 2015
176
Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast. 38
26472980 2015
177
A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes. 38
23242612 2015
178
Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer. 38
25112434 2015
179
Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients. 38
26183948 2015
180
Bilateral breast cancer following augmentation mammaplasty with polyacrylamide hydrogel injection: A case report. 38
26137129 2015
181
Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features. 38
25678442 2015
182
Radiation induced depigmentation disorder in two patients with breast cancer: Exploring a rare accompaniment. 38
25708302 2015
183
Sarcoma of the breast and chest wall after radiation treatment for bilateral breast carcinoma. 38
25788453 2015
184
The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. 38
25863477 2015
185
Stewart-Treves Syndrome after Bilateral Mastectomy and Radiotherapy for Breast Carcinoma: Case Report. 38
28331699 2015
186
Use of tomotherapy in treatment of synchronous bilateral breast cancer: dosimetric comparison study. 38
25605345 2015
187
Metabolic flare phenomenon on 18 fluoride-fluorodeoxy glucose positron emission tomography-computed tomography scans in a patient with bilateral breast cancer treated with second-line chemotherapy and bevacizumab. 38
25829734 2015
188
Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li-Fraumeni syndrome. 38
25226867 2015
189
Bilateral breast radiation delivered with static angle tomotherapy (TomoDirect): clinical feasibility and dosimetric results of a single patient. 38
25702655 2015
190
Intrafraction variability and deformation quantification in the breast. 38
25680602 2015
191
Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors. 38
26554380 2015
192
Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer. 38
25866690 2015
193
The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population. 38
25674498 2015
194
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 38
26399842 2015
195
Bilateral synchronous carcinoma breast- a rare case presentation. 38
25932376 2015
196
[Synchronous association of a bilateral breast cancer and a gastrointestinal stromal tumor: report of a rare case]. 38
26090003 2015
197
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden. 38
26082817 2015
198
A case of synchronous multiple bilateral breast cancer after breast augmentation. 38
26722625 2015
199
Surgical management for early-stage bilateral breast cancer patients in China. 38
25874699 2015
200
Bilateral breast cancer among three Yoruba women in a Nigerian teaching hospital. 38
30363615 2015
201
Impact of bilateral breast cancer on prognosis: synchronous versus metachronous tumors. 38
25735321 2015
202
Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up. 38
26163616 2015
203
[Synchronous bilateral breast cancer in Morocco: epidemiological and clinical characteristics]. 38
26090066 2015
204
Predictors for contralateral prophylactic mastectomy in breast cancer patients. 38
26097557 2015
205
Pancreatic intraepithelial neoplasia arising from an ectopic pancreas in the small bowel. 38
25475871 2014
206
Clinical manifestations and radiological features may contribute to the early diagnosis of radiation-induced sarcoma after breast cancer. 38
25266762 2014
207
[Using skin graft for local control in stage IV breast cancer to improve quality of life]. 38
25731370 2014
208
A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary breast cancer patients: a case-control study. 38
25409685 2014
209
A clinico-pathological study on cancer in sclerosing adenosis. 38
23408123 2014
210
[A case of malignant phyllodes tumor after surgery for breast cancer]. 38
25731378 2014
211
Primary squamous cell carcinoma of the breast after cured bilateral breast cancer. 38
25398815 2014
212
Are bilateral breast cancers and breast cancers coexisting with ovarian cancer different from solitary tumors? A pair-matched immunohistochemical analysis aimed at intrinsic tumor phenotype. 38
25296577 2014
213
Multiple primary cancers as a guide to heritability. 38
24945890 2014
214
The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India. 38
24894013 2014
215
Role of sonography in the differentiation of benign, high-risk, and malignant papillary lesions of the breast. 38
25154934 2014
216
Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry. 38
24633894 2014
217
Morphoimmunohistochemical characteristics of synchronous bilateral breast cancer. 38
25257431 2014
218
Bilateral synchronous breast cancer. 38
25420392 2014
219
Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies. 38
25007962 2014
220
Primary synchronous bilateral breast cancer. 38
25494117 2014
221
Periductal stromal tumor of the breast with synchronous bilateral breast cancer. 38
24982380 2014
222
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. 38
24951267 2014
223
The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China. 38
24961674 2014
224
Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan. 38
24800917 2014
225
An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report. 38
24969166 2014
226
[Metrorrhagia disclosing a synchronous bilateral breast cancer: report of a case]. 38
24411296 2014
227
Male breast cancer: presenting as synchronous, large, bilateral masses. 38
24959456 2014
228
Appearance of estrogen positive bilateral breast carcinoma with HER2 gene amplification in a patient with aplastic anemia. 38
25119012 2014
229
Appropriate evaluation of and risk factors for radiation dermatitis in breast cancer patients receiving hypofractionated whole-breast irradiation after breast-conserving surgery. 38
22492066 2014
230
Clinicopathological study of non-palpable familial breast cancer detected by screening mammography and diagnosed as DCIS. 38
22875640 2014
231
Missense mutations (p.H371Y, p.D438Y) in gene CHEK2 are associated with breast cancer risk in women of Balochistan origin. 38
24390236 2014
232
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer. 38
24498881 2014
233
A rare recurrence of bilateral breast cancer in the esophagus coincidentally associated with primary gastric cancer: a case report. 38
24533645 2014
234
Clinically significant missense variants in human GALNT3, GALNT8, GALNT12, and GALNT13 genes: intriguing in silico findings. 38
24038392 2014
235
Breast cancer and pacemakers. 38
23858021 2014
236
Serum p53 antibody in breast cancer. 38
24934362 2014
237
[Bilateral breast cancer: risk factors, prognostic factors and patient monitoring]. 38
25796820 2014
238
[Role of imaging procedures in the diagnosis of synchronous bilateral breast cancer]. 38
24309024 2014
239
A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors. 38
24736632 2014
240
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 38
24744928 2014
241
Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family. 38
23940062 2013
242
A case of synchronous bilateral breast cancer with different pathological responses to neoadjuvant chemotherapy with different biological character. 38
23875131 2013
243
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer. 38
24382440 2013
244
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma. 38
24373500 2013
245
A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer. 38
24382443 2013
246
Histo-biological comparative analysis of bilateral breast cancer. 38
24062258 2013
247
Evaluation of clinico: pathologic findings of breast carcinoma in a general hospital in Southern India. 38
24369200 2013
248
Chest wall sarcoma: 18F-FDG PET/CT in a patient with Li-Fraumeni syndrome. 38
24107814 2013
249
Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer. 38
24160328 2013
250
Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. 38
24042365 2013
251
Case report of small bowel obstruction caused by small intestinal metastasis of bilateral breast cancer. 38
24137245 2013
252
BRCA1 gene Molecular Alterations in Omani Breast Cancer Patients. 38
23996866 2013
253
Renal Medullary Carcinoma Masquerading as Bilateral Breast Carcinoma Category: Case Report. 38
29147351 2013
254
Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT. 38
23640240 2013
255
[Synchronous bilateral breast cancer in a male]. 38
23769252 2013
256
Primary dermal melanoma in a patient with a history of multiple malignancies: a case report with molecular characterization. 38
23904845 2013
257
A young woman with bilateral breast cancer: identifying a genetic cause and implications for management. 38
23667202 2013
258
The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients. 38
23296702 2013
259
Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation. 38
23104382 2013
260
Impact of presurgical breast magnetic resonance imaging (MRI) on surgical planning - a retrospective analysis from a private radiology group. 38
23294216 2013
261
[Bilateral breast cancer and Peutz-Jeghers syndrome]. 38
23254145 2013
262
Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil. 38
23406386 2013
263
Case report: Breast cancer associated with contralateral tuberculosis of axillary lymph nodes. 38
23432978 2013
264
Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy. 38
23149464 2013
265
Lymphedema. A significant health problem for women with breast cancer in Jordan. 38
23299161 2013
266
Nipple- or skin-sparing mastectomy and immediate breast reconstruction by the "moving window" operation. 38
22038670 2013
267
Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer. 38
23255899 2013
268
Cancer problem in Peutz-Jeghers syndrome. 38
23977663 2013
269
Synchronous bilateral solid papillary carcinomas of the breast. 38
23844308 2013
270
Synchronous bilateral breast cancer in a male. 38
24319497 2013
271
[Precursors of breast cancer]. 38
24325156 2013
272
[Bilateral breast cancer (epidemiological aspects)]. 38
23909045 2013
273
The molecular and clinicopathologic characteristics of bilateral breast cancer. 38
24005135 2013
274
Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence. 38
23083502 2012
275
Germline mutations in RAD51C in Jewish high cancer risk families. 38
23117857 2012
276
[A long-surviving case of HER2-positive breast cancer with brain metastasis treated by multidisciplinary therapy]. 38
23267980 2012
277
Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients. 38
22494589 2012
278
Papillary-serous adenocarcinoma of the uterine cervix during tamoxifen therapy after bilateral breast cancer. 38
23155282 2012
279
Less scarring or more symmetry? Reconstruction following metachronous bilateral breast cancer. 38
22560454 2012
280
Dosimetric advantages of generalised equivalent uniform dose-based optimisation on dose-volume objectives in intensity-modulated radiotherapy planning for bilateral breast cancer. 38
23091290 2012
281
Clinical impact of (18)F-FDG PET/CT on initial staging and therapy planning for breast cancer. 38
23170128 2012
282
Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary. 38
23091540 2012
283
A case of synchronous metastasis of breast cancer to stomach and colon. 38
22993359 2012
284
Tumor seeding after diagnostic vitrectomy for choroidal metastasis in breast cancer. 38
22989547 2012
285
Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review. 38
23691479 2012
286
[Diagnosis of metachronous bilateral breast cancer]. 38
23350406 2012
287
Radiofrequency thermoablation in locally advanced breast cancer. 38
22386281 2012
288
Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients. 38
22438049 2012
289
Three cases of kindred with familial breast cancer in which carrier detection by BRCA gene testing was performed on family members. 38
19806429 2012
290
Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. 38
22713658 2012
291
Circulating tumour cells in non-metastatic breast cancer: a prospective study. 38
22677156 2012
292
Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature. 38
22672556 2012
293
Synchronous bilateral male breast cancer: a case report. 38
22807945 2012
294
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study. 38
22382806 2012
295
Is short-interval mammography necessary after breast conservation surgery and radiation treatment in breast cancer patients? 38
22245193 2012
296
Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients. 38
21945313 2012
297
Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer. 38
22237454 2012
298
SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation. 38
22469291 2012
299
Synchronous bilateral breast cancer in a patient with kindler syndrome. 38
22054710 2012
300
[The clinical study of familial breast cancer - now and the problems]. 38
22504672 2012
301
Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer. 38
22520019 2012
302
Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience. 38
21193967 2012
303
Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique. 38
22019349 2012
304
Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer. 38
22816241 2012
305
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing. 38
21553119 2012
306
Clinicopathological features in bilateral breast cancer. 38
23167382 2012
307
Synchronous bilateral breast carcinoma and axillary non-hodgkin lymphoma: a case report and review of the literature. 38
23050177 2012
308
Survival from synchronous bilateral breast cancer: the experience of surgeons participating in the breast audit of the Society of Breast Surgeons of Australia and New Zealand. 38
22799341 2012
309
Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients. 38
21847643 2012
310
Synchronous bilateral medullary carcinoma of breast: is it metastasis or second primary? 38
22531532 2012
311
Estrogen receptor, progesterone receptor, and Her 2 Neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan. 38
23304239 2012
312
A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. 38
22105824 2011
313
Pregnancy a short time after multimodal therapy for bilateral breast cancer: a case report and review of literature. 38
20858636 2011
314
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. 38
22185575 2011
315
[A case of scalp metastases from breast cancer successfully treated with letrozole]. 38
22202323 2011
316
Bilateral primary breast neuroendocrine carcinoma in a young woman: report of a case. 38
21969166 2011
317
Perceptions of contralateral breast cancer: an overestimation of risk. 38
21947590 2011
318
A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer. 38
21989022 2011
319
Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study. 38
21553118 2011
320
Preoperative Systemic Treatment in BRCA-Positive Breast Cancer Patients: Case Report and Review of the Literature. 38
22619651 2011
321
The Korean Hereditary Breast Cancer (KOHBRA) study: protocols and interim report. 38
21497495 2011
322
Detection of bilateral breast cancer at biennial screening mammography in the Netherlands: a population-based study. 38
21474705 2011
323
Prognosis of early-stage synchronous bilateral invasive breast cancer. 38
21628090 2011
324
Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. 38
22109790 2011
325
Helical tomotherapy in patients with breast cancer and complex treatment volumes. 38
21493188 2011
326
Electron arc therapy for bilateral chest wall irradiation: treatment planning and dosimetric study. 38
21185700 2011
327
PALB2 mutations in German and Russian patients with bilateral breast cancer. 38
21165770 2011
328
Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. 38
21093260 2011
329
Current status of diagnosis and treatment of primary breast cancer in beijing, 2008. 38
23467615 2011
330
Solitary small bowel metastasis from breast cancer. 38
21847398 2011
331
Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution. 38
20972632 2011
332
[A case of possible retroperitoneal metastasis of breast cancer successfully treated with oral S-1 and cyclophosphamide therapy after TC therapy]. 38
21403449 2011
333
Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. 38
20665107 2011
334
Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management. 38
20204556 2011
335
Bilateral DCIS following gynecomastia surgery. Role of nipple sparing mastectomy. A case report and review of literature. 38
22096697 2011
336
[Li-Fraumeni syndrome: clinico-molecular diagnostics and medico-genetic counseling]. 38
22379889 2011
337
Bilateral breast cancer: a male patient. 38
21954546 2011
338
Bilateral breast carcinoma- a rare case report. 38
21505580 2011
339
The risk factors and prognosis of bilateral primary breast cancer: a comparative study with unilateral breast cancer. 38
21473293 2011
340
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. 38
20838878 2011
341
Concurrent breast stroma sarcoma and breast carcinoma: a case report. 38
21182764 2010
342
Non-founder BRCA1 mutations in Russian breast cancer patients. 38
20727672 2010
343
[A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock]. 38
21160270 2010
344
Bilateral breast carcinoma: clinical characteristics and its impact on survival. 38
21070440 2010
345
Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America. 38
20875877 2010
346
Early results of an endoscopic nipple-sparing mastectomy for breast cancer. 38
22695768 2010
347
Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer. 38
20582466 2010
348
BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries. 38
20472656 2010
349
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer. 38
19875753 2010
350
Synchronous bilateral breast carcinoma with two different morphology subtypes: a case report. 38
20698158 2010
351
Bilateral breast cancer in a survivor of acute lymphoblastic leukemia: a case report. 38
19472087 2010
352
Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer. 38
20211870 2010
353
Evaluating cancer epidemiologic risk factors using multiple primary malignancies. 38
20299982 2010
354
Erdheim-chester disease presenting as bilateral clinically malignant breast masses. 38
20216377 2010
355
Severe venous and lymphatic obstruction after single-chamber pacemaker implantation in a patient with chest radiation therapy. 38
20025702 2010
356
Synchronous bilateral breast cancer in a patient with Klinefelter's syndrome. 38
20463819 2010
357
Ovarian metastases from breast cancer: report of 29 cases. 38
20041486 2010
358
Four different malignancies in one patient: a case report. 38
20205852 2010
359
Case report. PET/CT appearance of desmoid tumour of the chest wall. 38
20139256 2010
360
Clinical experience with image-guided radiotherapy in an accelerated partial breast intensity-modulated radiotherapy protocol. 38
19467799 2010
361
[Microsatellite instability of bilateral breast carcinomas is not linked to down-regulated expression of DNA mismatch repair genes]. 38
20552889 2010
362
Synchronous bilateral breast cancer in an aged male patient. 38
20502060 2010
363
Bilateral breast carcinoma in patients with Klinefeleter syndrome: report of case. 38
21246928 2010
364
Synchronous bilateral breast carcinoma in a patient with cowden syndrome: a case report with morphologic, immunohistochemical and genetic analysis. 38
19968660 2010
365
Early results of an endoscopic nipple-sparing mastectomy for breast cancer. 38
19662457 2009
366
[A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel]. 38
20037459 2009
367
Cutaneous angiosarcoma after breast conserving treatment for bilateral breast cancers in a BRCA-1 gene mutation carrier--a case report and review of the literature. 9
19736894 2009
368
Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy. 38
19630947 2009
369
Recovery of ventricular function with a left ventricular axial pump in a patient with end-stage toxic cardiomyopathy not a candidate for heart transplantation: first experience in Spain. 38
19715885 2009
370
No breast cancer association for transforming growth factor-beta pathway colorectal cancer single nucleotide polymorphisms. 38
19505925 2009
371
Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer. 38
19593618 2009
372
Scintimammography with high resolution dedicated breast camera and mammography in multifocal, multicentric and bilateral breast cancer detection: a comparative study. 38
18432183 2009
373
Prognosis of synchronous bilateral breast cancer. 38
19283743 2009
374
Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci. 38
19147119 2009
375
Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women. 38
19190627 2009
376
[Three cases of second primary lung cancer after radiotherapy for breast cancer]. 38
19198231 2009
377
Hypercalcaemia in breast cancer patients: not always bony metastases. 38
21686968 2009
378
Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls. 38
19124502 2009
379
Synchronous bilateral mucinous carcinoma of the breast: case report. 38
19135933 2009
380
Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene. 38
19127115 2008
381
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. 38
18556141 2008
382
Adjacent thoracic lymph node metastases originating from two separate primary cancers: case report. 38
18831741 2008
383
Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinoma. 38
18469799 2008
384
Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. 38
19016756 2008
385
Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. 38
18722264 2008
386
Breast cancer onset in twins and women with bilateral disease. 38
18591548 2008
387
A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach. 38
18704915 2008
388
Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. 38
18783588 2008
389
A family history of breast cancer will not predict female early onset breast cancer in a population-based setting. 38
18651949 2008
390
A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer. 38
18558293 2008
391
Bilateral Paget disease of the male nipple: first report. 38
18171616 2008
392
Primary lymphoma of the breast involving both axillae with bilateral breast carcinoma. 38
18492251 2008
393
Assessment of surgical treatment in elderly patients with breast cancer. 38
18705397 2008
394
Bilateral breast cancer in a male patient with hepatocellular carcinoma. A case report. 38
18727274 2008
395
Synchronous bilateral breast cancer with different biological profile and estrogen-progesterone receptor status. 38
18298610 2008
396
Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group. 38
18250348 2008
397
Clinicopathological characteristics of synchronous bilateral breast carcinomas. Report of 30 patients. 38
18444533 2008
398
Case 32-2007: bilateral breast cancer. 38
18305276 2008
399
Role of sonography in the detection of contralateral metachronous breast cancer in an Asian population. 38
18212235 2008
400
Correlation of whole-breast vascularity with ipsilateral breast cancers using contrast-enhanced MDCT. 38
18212238 2008
401
Significance of irradiation in breast-conserving treatment: comparison of local recurrence rates in irradiated and nonirradiated groups. 38
18307014 2008
402
Mutation analysis of the MDM4 gene in German breast cancer patients. 38
18279506 2008
403
Bilateral breast MR imaging: is it superior to conventional methods for the detection of contralateral breast cancer? 38
18317885 2008
404
Detection of bilateral, multifocal breast cancer and assessment of tumour response to neoadjuvant chemotherapy by Tc-99m sestamibi imaging - a case report. 38
19585458 2008
405
Simultaneous diagnosis and treatment of bilateral breast carcinoma and endometrial adenocarcinoma. Implications for screening. 38
19051825 2008
406
[Synchronous bilateral breast cancer: risk factors, diagnosis, histology and treatment]. 38
18178120 2008
407
Oncoplastic surgery after mammary reduction and mastopexy for bilateral breast cancer lesions: report of a case. 38
18368323 2008
408
Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival. 38
18269777 2007
409
Survival after bilateral breast cancer: results from a population-based study. 38
17186359 2007
410
Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision. 38
17629481 2007
411
Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation. 38
17572079 2007
412
Incidence and prognosis of synchronous and metachronous bilateral breast cancer. 38
17878475 2007
413
Searching for susceptibility alleles: emphasis on bilateral breast cancer. 38
17444500 2007
414
Bilateral breast cancer: differential diagnosis using histological and biological parameters. 38
17673471 2007
415
[Simultaneous bilateral breast carcinoma--case study and review of primitive bilateral breast cancer]. 38
17966947 2007
416
Bilateral male breast cancer with male potential hypogonadism. 38
17543123 2007
417
Incidental discovery of bilateral breast cancer in a 24-year-old man presenting with gynecomastia. 38
17522493 2007
418
Use of ultrasonography as an alternative modality for first-line examination in detecting breast cancer in selected patients. 38
17592675 2007
419
Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India. 38
17519044 2007
420
Synchronous bilateral breast cancer in men: a case report and review of the literature. 38
17557578 2007
421
Genetic changes in bilateral breast cancer by comparative genomic hybridisation. 38
17380298 2007
422
Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. 38
17206485 2007
423
Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia. 38
17333477 2007
424
Mucinous cystadenoma arising in an isolated ileal duplication cyst. 38
19089665 2007
425
US findings of bilateral primary breast cancer: retrospective study. 38
17064869 2007
426
Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. 38
17244989 2007
427
Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. 38
16978974 2006
428
[Case report of advanced breast cancer responding to capecitabine and trastuzumab combination therapy]. 38
17033236 2006
429
Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent. 38
16965326 2006
430
[Onycholysis with hyponychium exudate secondary to chemotherapy with paclitaxel and capecitabine]. 38
17067535 2006
431
[Bilateral breast cancer (BBC). Considerations on a series of 20 cases]. 38
17438890 2006
432
Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan. 38
16544057 2006
433
Human leukocyte antigen as a predictive factor of developing bilateral breast cancer in Japanese women. 38
16959002 2006
434
Family history of breast cancer as a risk factor for ovarian cancer in a prospective study. 38
16881078 2006
435
Clinical significance of CK5/6 and PTEN protein expression in patients with bilateral breast carcinoma. 38
16918971 2006
436
HER2 status in bilateral breast cancer. 38
17269588 2006
437
Diabetes insipidus and adrenal insufficiency in a patient with metastatic breast cancer. 38
16990696 2006
438
ATM variants and cancer risk in breast cancer patients from Southern Finland. 38
16914028 2006
439
On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer. 38
16496408 2006
440
Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. 38
16770759 2006
441
Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family. 38
16772121 2006
442
[Secondary breast bilateral reconstruction with myocutaneous pedicled latissimus dorsi flap after primary bilateral skin sparing mastectomy reconstruction with consecutive severe capsular contraction]. 38
17087135 2006
443
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. 38
16737811 2006
444
[Expression and clinical significance of KNSL4 in breast cancer]. 38
16764773 2006
445
Synchronous breast cancer in spouses. 38
16869244 2006
446
Evolving concepts in the management of lobular neoplasia. 38
16687097 2006
447
Histopathological types of breast cancer in Nigerian women: a 12-year review (1993-2004). 38
16999196 2006
448
High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma. 38
16475207 2006
449
A case of bilateral breast cancer with Peutz-Jeghers syndrome. 38
16246518 2006
450
[Bilateral breast bacterial cellulite secondary to Streptococcus agalactiae septicemia]. 38
16508605 2006
451
A case of metachronous bilateral breast cancer with bilateral radiation pneumonitis after breast-conserving therapy. 38
16929127 2006
452
Synchronous bilateral breast carcinoma in a 50-year-old man with 45,X/46,XY mosaic karyotype: report of a case. 38
16378198 2006
453
Primary gynecological neoplasms and clinical outcomes in patients diagnosed with breast carcinoma. 38
16515578 2006
454
Low frequency of the CHEK2*1100delC mutation among breast cancer probands from three regions of Poland. 38
16830057 2006
455
Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County. 38
16858627 2006
456
[Breast cancer and pregnancy: a study of 3 cases]. 38
16450949 2005
457
Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population. 38
16136597 2005
458
Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. 38
16257342 2005
459
Simultaneous bilateral breast cancer in a male: a case report and review of the literature. 38
16315841 2005
460
Synchronous bilateral Paget's disease of the nipple associated with bilateral breast carcinoma. 38
16174159 2005
461
Complementary role of adjunctive breast magnetic resonance imaging and scintimammography in patients of all ages undergoing breast cancer surgery. 38
16026435 2005
462
Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel. 38
16030426 2005
463
Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile. 38
15944928 2005
464
Genetic implications of bilateral breast cancer: a population based cohort study. 38
15925815 2005
465
Breast-conserving therapy in patients with bilateral breast cancer: do today's treatment choices burn bridges for tomorrow? 38
15890578 2005
466
Bilateral breast cancer. Incidence, diagnosis and histological patterns. 38
15900371 2005
467
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. 38
15578693 2005
468
[Three cases of advanced breast cancer successfully treated with a weekly dose of paclitaxel]. 38
15853223 2005
469
Synchronous bilateral breast cancer in an elderly man. 38
15730469 2005
470
Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ. 38
15827818 2005
471
Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients. 38
15472904 2005
472
Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer. 38
16168123 2005
473
[The bilateral breast cancer in patient treated for Ewing sarcoma in childhood--the case report]. 38
16786799 2005
474
High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. 38
16168118 2005
475
Bilateral breast-conserving therapy for bilateral breast cancer: results and consideration of radiation technique. 38
15858445 2005
476
Genetics and the young woman with breast cancer. 38
16823163 2005
477
The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer. 38
16110289 2005
478
Morphologically similar epithelial and stromal cells in primary bilateral breast tumors display different genetic profiles: implications for treatment. 38
15536329 2004
479
[Breast cancer and quality of life--improvement by contralateral breast reconstruction and symmetrical mammaplasty?]. 38
15633083 2004
480
Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. 38
15507181 2004
481
A case of bilateral breast cancer and Graves' disease. 38
15656338 2004
482
Prenatal diagnosis in Li-Fraumeni syndrome. 38
15342977 2004
483
Management of bilateral breast carcinoma: long-term results. 38
15521255 2004
484
Bilateral autogenous breast reconstruction using perforator free flaps: a single center's experience. 38
15220573 2004
485
Metastasis of breast carcinoma to intracranial meningioma. 38
15550902 2004
486
Phenotypic similarities in bilateral breast cancer. 38
15111764 2004
487
Contrast-enhanced MR imaging of breast lesions and effect on treatment. 38
15135477 2004
488
Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors. 38
15017434 2004
489
A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls. 38
15042666 2004
490
Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. 38
15082902 2004
491
A case of fat necrosis after breast quadrantectomy in which preoperative diagnosis was enabled by MRI with fat suppression technique. 38
15010123 2004
492
[Bilateral breast cancer. Incidence and risk factors]. 38
15123135 2004
493
Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama. 38
15280184 2004
494
Molecular study of clonality in multifocal and bilateral breast tumors. 38
15648612 2004
495
The pattern of gene copy number changes in bilateral breast cancer surveyed by cDNA microarray-based comparative genomic hybridization. 38
14654965 2004
496
Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers. 38
14997059 2004
497
Risk estimation for healthy women from breast cancer families: new insights and new strategies. 38
14744738 2004
498
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. 38
15084244 2004
499
The DNMT3B C-->T promoter polymorphism and risk of breast cancer in a British population: a case-control study. 38
15217506 2004
500
Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. 38
14574485 2003
501
Malignant mixed mullerian tumor of the ovary and bilateral breast cancer: an argument for BRCA3, or a coincidental cluster of unconnected cancers? 38
14599878 2003
502
Molecular cytogenetic investigations of synchronous bilateral breast cancer. 38
12944548 2003
503
Therapeutic controversies in bilateral breast cancer. 38
12924462 2003
504
[Anesthesia for a patient with Kartagener's syndrome undergoing ambulatory bilateral breast cancer surgery]. 38
13677279 2003
505
[Bilateral breast cancer]. 38
12903583 2003
506
[Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer]. 38
12883794 2003
507
Heart transplantation in chemotherapeutic dilated cardiomyopathy. 38
12826209 2003
508
Bilateral breast cancer associated with diffuse scleroderma. 38
14659331 2003
509
Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation. 38
12798754 2003
510
Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer. 38
12752622 2003
511
Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. 38
12715337 2003
512
Synchronous, bilateral breast cancer: prognostic value and incidence. 38
14659335 2003
513
Molecular pathogenesis of bilateral breast cancer. 38
12609703 2003
514
Synchronous bilateral breast cancer with Paget's disease and invasive ductal carcinoma: report of a case. 38
12924421 2003
515
Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire. 38
12558666 2003
516
Primary squamous cell carcinoma of the breast. 38
14584651 2003
517
Factors influencing mortality among young women with second primary breast carcinoma. 38
12412157 2002
518
Distinct prevalence of the CYP19 Delta3(TTTA)(7) allele in premenopausal versus postmenopausal breast cancer patients, but not in control individuals. 38
12204674 2002
519
Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas. 38
12124805 2002
520
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. 38
12094328 2002
521
The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours. 38
12099647 2002
522
Breast-conservation treatment for bilateral breast cancer in five Japanese women. 38
11956611 2002
523
Lumpectomy and breast radiotherapy in breast cancer patients with a family history of breast cancer, ovarian cancer, or both. 38
12047472 2002
524
Bilateral synchronous breast cancer and HER-2/neu overexpression. 38
12058961 2002
525
Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. 38
12473175 2002
526
Histological grade, p53, HER2 and hormone receptor status of synchronous bilateral breast carcinoma. 38
12016392 2002
527
Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases. 38
12459717 2002
528
Bilateral breast cancer. 38
12044060 2002
529
Limitations of the Gail model in the specialized breast cancer risk assessment clinic. 38
11856157 2002
530
Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population. 38
12362976 2002
531
Tubular breast cancer experience at Washington University: a review of the literature. 38
11899414 2001
532
Prognostic significance of synchronous and metachronous bilateral breast cancer. 38
11571945 2001
533
Multifocal squamous cell carcinoma of the oesophagus following radiotherapy for bilateral breast carcinoma. 38
11533082 2001
534
[A case of breast cancer with bone marrow and liver metastases responding completely to low-dose weekly paclitaxel combined with toremifene]. 38
11579642 2001
535
Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. 38
11504767 2001
536
Leiomyomatosis peritonealis disseminata and ovarian Brenner tumor associated with tamoxifen use. 38
11520371 2001
537
[Bilateral breast carcinoma and local recurrence: prevalence of BRCA-1 and BRCA-2 gene mutations in an unselected patient sample]. 38
11505617 2001
538
Understanding mathematical models for breast cancer risk assessment and counseling. 38
11678799 2001
539
Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male. 38
11434671 2001
540
[Arm morbidity after axillary dissection for breast cancer]. 38
11434124 2001
541
Caucasian family with two independent mutations: 2594delC in BRCA1 and 5392delAG in BRCA2 gene. 38
11391658 2001
542
[Sentinel lymph node biopsy in breast cancer: a validation study and preliminary results]. 38
11420841 2001
543
Contralateral breast cancer: molecular differentiation between metastasis and second primary cancer. 38
11518461 2001
544
Radioimmunoguided breast surgery using radiolabeled antibody NR-LU-10 FAB: a pilot study. 38
11504368 2001
545
A case-control study of unilateral and bilateral breast carcinoma patients. 38
11346865 2001
546
Differences in estrogen receptor status, HER2, and p53 comparing metachronous bilateral breast carcinoma. 38
11344480 2001
547
Bilateral breast cancer--under age 20 years. 38
11287255 2001
548
What about the other breast? A review of a series of bilateral breast carcinomas. 38
14965575 2001
549
[Particular clinical aspect of breast cancer]. 38
12731152 2001
550
Radiation-induced chromatid breaks as a predictor of breast cancer risk. 38
11173151 2001
551
The diagnostic accuracy of mammography in the evaluation of male breast disease. 38
11425067 2001
552
Protein accumulation and gene mutation of p53 in bilateral breast cancer. South-East Sweden Breast Cancer Group. 38
11321662 2001
553
Familial breast cancer: an investigation into the outcome of treatment for early stage disease. 38
14573999 2001
554
3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: clinical results and future perspectives with reference to FDG-PET. 38
11791129 2001
555
Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. 38
11094304 2000
556
Loss of heterozygosity in bilateral breast cancer. 38
11200774 2000
557
Local-regional control in breast cancer patients with a possible genetic predisposition. 38
11072150 2000
558
[Germ-line mutations of the BRCA1 gene in northeastern France]. 38
11084537 2000
559
Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. 38
11015105 2000
560
Familial cancer risks to offspring from mothers with 2 primary breast cancers: leads to cancer syndromes. 38
10962444 2000
561
Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients. 38
10952774 2000
562
CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women. 38
10840158 2000
563
The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy. 38
11038147 2000
564
[Characteristics of familial breast cancer]. 38
10921313 2000
565
Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. 38
10870056 2000
566
Incidence and Detection of Contralateral Breast Cancer. 38
11348361 2000
567
Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery. 38
10861612 2000
568
Multiple radiculopathy of the lower limbs in a cancer patient with meningeal carcinomatosis. 38
10938191 2000
569
Bilateral male breast cancer and prostate cancer: a case report. 38
10830988 2000
570
[++Scintimammography: a new imaging technique for diagnosis and follow-up of breast cancer]. 38
10827352 2000
571
Prophylactic mastectomy: pathologic findings in high-risk patients. 38
10705389 2000
572
Management of breast cancer after Hodgkin's disease. 38
10673517 2000
573
ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. 38
10677309 2000
574
Linkage analysis and loss of heterozygosity for chromosome arm 1p in familial breast cancer. 38
10398429 1999
575
Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging. The role of delayed imaging. 38
10439180 1999
576
BRCA1 mutations in African Americans. 38
10480351 1999
577
Bilateral breast carcinomas: do they have similar mammographic features? 38
10437693 1999
578
Familial risks in second primary breast cancer based on a family cancer database. 38
10448299 1999
579
[A case of pleural and mediastinal lymph node metastases from breast cancer effectively treated with fadrozole hydrochloride in combination with cyclophosphamide]. 38
10065105 1999
580
Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study. 38
10027348 1999
581
Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer. 38
10030422 1999
582
Efficacy of Breast Conservation Therapy in Early Stage Bilateral Breast Cancer. 38
11348254 1999
583
Quadruple cancer including bilateral breasts, Vater's papilla, and urinary bladder: report of a case. 38
10192743 1999
584
Evolving perspectives in contralateral breast cancer. 38
10070301 1998
585
[Vaginal metastases of breast cancer]. 38
9921442 1998
586
Bilateral Synchronous Spindle Cell, Apocrine and Scirrhous Carcinoma Breast Cancer in a Case of Malignant Lymphoma. 38
11091684 1998
587
Efficacious diagnosis of primary and metastatic human carcinomas with a combination of p53 mutation analysis and clonality analysis of androgen receptor gene. 38
9735408 1998
588
Microsatellite instability in breast cancers with special reference to patients' age and bilaterality. 38
9810779 1998
589
[The incidence of bilateral multiple primary breast cancer among the female inhabitants of Crimea]. 38
9844902 1998
590
Association of breast cancer with meningioma. 38
9725004 1998
591
BRCA1 mutations in southern England. 38
9649133 1998
592
Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour? 38
9797693 1998
593
BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. 38
9544766 1998
594
[Bilateral breast carcinoma--a retrospective analysis of 27 patients with a case report]. 38
9594636 1998
595
[Orbital and stomach metastasis from invasive lobular breast carcinoma]. 38
9513361 1998
596
p53 mutations in bilateral breast carcinoma. Correlation with Ki-67 expression and the mean nuclear volume. 38
9464497 1998
597
Bilateral synchronous spindle cell, apocrine and scirrhous carcinoma breast cancer in a case or malignant lymphoma. 38
18843558 1998
598
[Bilateral breast cancer with neuroendocrine differentiation and a long course]. 38
9807215 1998
599
Mammographic and ultrasonographic findings in bilateral breast cancer: a comparative study. 38
9569339 1998
600
Medico-genetic and cytogenetic study of a family with high predisposition to malignant disease in gastro-intestinal tract. 38
9505210 1997
601
Bilateral breast carcinoma versus unilateral disease. Review of 498 patients. 38
9391536 1997
602
Clinicopathological Features of Hereditary Breast Cancer. 38
11091606 1997
603
Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation: the University of Pennsylvania experience. 38
9276360 1997
604
Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. 38
9142379 1997
605
Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma. 38
9083159 1997
606
Diet and premenopausal bilateral breast cancer: a case-control study. 38
9065608 1997
607
[Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases]. 38
9435820 1997
608
Pituitary adenoma and bilateral male breast cancer: an unusual association. 38
9040805 1997
609
Genetics of breast cancer. 38
9005288 1997
610
Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. 38
10464625 1997
611
Hereditary breast cancer in Northern Ireland. 38
8979776 1996
612
[Solitary fibrous tumor of the pleura. Clinical case]. 38
8992400 1996
613
Dermatomyositis and malignancy: case report and review of the Japanese literature. 38
8693612 1996
614
Clonal analysis of bilateral breast cancer. 38
9816225 1996
615
Epidemiology of susceptibility to breast cancer. 38
8895988 1996
616
[Bilateral breast carcinoma. 12 years' experience]. 38
8677043 1996
617
Mutations in the BRCA1 gene in Japanese breast cancer patients. 9
8723683 1996
618
A case-control study of reproductive variables, alcohol, and smoking in premenopausal bilateral breast cancer. 38
8750527 1996
619
Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer. 38
8847135 1995
620
Comparison of p53 gene abnormalities in bilateral and unilateral breast cancer. 38
8625077 1995
621
Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. 38
8625076 1995
622
Four Cases of Familial Breast Cancer. 38
11091545 1995
623
Bilateral breast cancer: early detection with mammography. 38
7617856 1995
624
Bilateral breast carcinoma: mammographic and histologic correlation. 38
7753983 1995
625
The first documentation of Li-Fraumeni syndrome in Korea. 38
8527048 1995
626
[Bilateral breast carcinoma after recurrent myxoid liposarcoma of the breast]. 38
7792276 1995
627
Mutations of the p53 gene in male breast cancer. 38
7712430 1995
628
The role of p53 mutations in bilateral breast carcinoma. 38
7617647 1995
629
[The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups]. 38
7740408 1995
630
Bilateral breast carcinoma after radiation therapy for Hodgkin's disease. 38
7839173 1995
631
Breast cancer in adolescent females. 38
7738758 1995
632
Early adult body weight, body mass index, and premenopausal bilateral breast cancer: data from a case-control study. 38
7749135 1995
633
Bilateral Breast Cancer in a Patient with a Strong Family History of Cancer: Analysis of p53 Germ Line Mutations. 38
11091524 1994
634
Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. 38
8083126 1994
635
Simultaneous bilateral malignant breast neoplasms in Nigerian women. 38
8046764 1994
636
Differentiation of primary and secondary breast cancer with clonal analysis. 38
7909387 1994
637
[Genetic epidemiology and a matched case-control study of bilateral breast cancer in Shanghai]. 38
7924649 1994
638
Prognostic factors in bilateral breast cancer. 38
7870220 1994
639
Clinical epidemiology of bilateral breast cancer. 38
8252478 1993
640
Bilateral breast cancer. 38
8239195 1993
641
Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene, in 64 families with premenopausal bilateral breast cancer. 38
8221639 1993
642
[Bilateral carcinoma of the breast]. 38
8080156 1993
643
Immediate, bilateral transverse rectus abdominis musculocutaneous (TRAM) flap reconstruction after mastectomy. 38
8338283 1993
644
Familial breast cancer risks. Effects of prostate and other cancers. 38
8508396 1993
645
Subcutaneous mastectomy with axillary dissection for early breast cancer. 38
8352542 1993
646
[Bilateral breast cancer]. 38
8170828 1993
647
Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. 38
8479749 1993
648
Bilateral breast cancer in a male? Case report. 38
8057334 1993
649
A linkage analysis of D17S74 (CMM86) in thirty-five families with premenopausal bilateral breast cancer. 38
8417809 1993
650
The pattern of diagnosis of a second primary tumor in the breast. 38
8369522 1993
651
Linkage mapping in familial breast cancer: improved localisation of a susceptibility locus on chromosome 17q12-21. 38
8425756 1993
652
Reporting bilaterality status in first-degree relatives with breast cancer: a validity study. 38
8224805 1993
653
Management of cancer of the opposite breast following breast preservation. 38
1336002 1992
654
[Bilateral breast tumors]. 38
1467150 1992
655
The genetic epidemiology of second primary breast cancer. 38
1456270 1992
656
Oral contraceptives and premenopausal bilateral breast cancer: a case-control study. 38
1391133 1992
657
Misdiagnosis of bilateral breast cancer. 38
1498733 1992
658
[Chromosome and DNA analyses of peripheral blood lymphocyte from the quadruple cancer patient]. 38
1626941 1992
659
Absence of p53 germ-line mutations in bilateral breast cancer patients. 38
1587536 1992
660
[Bilateral primary breast cancer. An analysis of 64 cases]. 38
1337736 1992
661
Transmission of breast cancer--a controversy resolved. 38
1576759 1992
662
Family history and risk of breast cancer. 38
1552556 1992
663
[Li-Fraumeni syndrome and the p53 gene]. 38
1557756 1992
664
Mammography in hospital patients: use and misuse. 38
1573600 1992
665
Multicentric breast tumour: an anatomical-clinical study of 100 cases. 38
1737589 1992
666
Long-term effects of adjuvant tamoxifen and/or radiotherapy. The South Sweden Breast Cancer Trial. 38
1622645 1992
667
Bilateral breast cancer. 38
1775816 1991
668
Inheritance of proliferative breast disease in breast cancer kindreds. 38
2270486 1990
669
Bilateral breast cancer. 38
2218824 1990
670
[Chest wall reconstruction using a free rectus abdominis myocutaneous flap in a case of recurrence after bilateral breast cancer surgery]. 38
2148344 1990
671
[Treatment and prognosis of metachronous bilateral carcinoma of the breast]. 38
2177859 1990
672
Bilateral breast carcinoma: 28 years' experience. 38
2382457 1990
673
Bilateral breast cancer after cured Hodgkin's disease. 38
2295045 1990
674
Genetic epidemiology of bilateral breast cancer: a linkage analysis using the affected-pedigree-member method. 38
2328913 1990
675
[Relationship of breast cancer and HLA in Japanese females]. 38
2299789 1990
676
Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. 38
2777405 1989
677
Bilateral breast carcinoma treated with definitive irradiation. 38
2546905 1989
678
A genetic epidemiologic investigation of breast cancer in families with bilateral breast cancer. II. Linkage analysis. 38
2766568 1989
679
Bilateral breast cancer. 38
2545121 1989
680
[Bilateral carcinoma of the breast]. 38
2682362 1989
681
The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease. 38
2710953 1989
682
[Bilateral malignancy of the breast]. 38
2618327 1989
683
Predicting survival in bilateral breast carcinoma. 38
2913992 1989
684
Rare clonal karyotypic variants in primary cultures of human breast carcinoma cells. 38
2910462 1989
685
Primary synchronous bilateral breast cancer: epidemiological approach. 38
3228594 1988
686
Familial and sporadic breast cancer cases in Iceland: a comparison related to ABO blood groups and risk of bilateral breast cancer. 38
3170024 1988
687
Late pericardial tamponade following radiation therapy for bilateral breast carcinoma. 38
3180802 1988
688
Prognosis in bilateral breast cancer. Effects of time interval between first and second primary tumours. 38
3166909 1988
689
Estrogen receptors in bilateral breast cancer. 38
3383109 1988
690
Bilateral primary breast cancer in patients treated with adjuvant therapy. 38
3128945 1988
691
Possible heterogeneity in the segregation pattern of breast cancer in families with bilateral breast cancer. 38
3402724 1988
692
Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. 38
3334958 1988
693
[A case of familial breast cancer--identical twin sisters with a heterochronic bilateral breast cancer that developed at the same age]. 38
3694810 1987
694
Late deaths and second primary malignancies among long-term survivors of childhood cancer: an Italian multicentre study. 38
3653174 1987
695
A genetic epidemiologic investigation of breast cancer in families with bilateral breast cancer. I. Segregation analysis. 38
3472000 1987
696
Occult breast cancer: prevalence and radiographic detectability. 38
3562827 1987
697
Tumor-associated antigens in bilateral breast cancer. 38
2437406 1987
698
[The breast cancer-prone family: clinical study of familial breast cancer]. 38
3599458 1987
699
Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections. 38
3574239 1987
700
Elective whole-lung irradiation in osteosarcoma treatment: appearance of bilateral breast cancer in two long-term survivors. 38
3472355 1987
701
Primary bilateral breast cancer. 38
3025460 1986
702
Bilateral breast carcinoma: prospective evaluation of factors assisting diagnosis. 38
3736061 1986
703
Bilateral breast cancer: the frequency of undiagnosed cancers. 38
3017110 1986
704
[Nursing of a patient with bilateral breast cancer developing at different times and followed by repeated recurrences and metastases]. 38
3640172 1986
705
[Nongynecological occult cancers diagnosed in the course of their ovarian metastases. A clinical and anatomicopathological study of 8 cases]. 38
3016885 1986
706
Histiocytoid carcinoma: a variant of breast cancer. 38
2425190 1986
707
Risk factors of multiple primary cancers in breast cancer patients. 38
3084420 1986
708
Lobular carcinoma of the breast in a patient with Klinefelter's syndrome. A case with bilateral, synchronous, histologically different breast tumors. 38
3002597 1986
709
Has monitoring of the contralateral breast improved the prognosis in patients treated for primary breast cancer? 38
3942996 1986
710
[Bilateral breast cancer]. 38
3951147 1986
711
[Bilateralization of breast cancer]. 38
3730633 1986
712
Tumorectomy plus radiotherapy in the management of breast cancer. 38
4082289 1985
713
Comparison between the nuclear diameters of primary and metastatic breast cancer cells obtained by cytologic aspiration. 38
2992740 1985
714
Bilateral breast cancer. 38
4079423 1985
715
Bilateral breast cancer. Risk reduction by contralateral biopsy. 38
4004380 1985
716
Carcinoma of the breast in three siblings. 38
2986822 1985
717
[Intra-arterial infusion chemotherapy and transcatheter arterial chemo-embolization for patients with simultaneous bilateral breast cancer]. 38
3994399 1985
718
Family history and the risk of breast cancer. 38
3974080 1985
719
[Bilateral breast carcinoma]. 38
2984536 1985
720
Survival in bilateral breast cancer. 38
3971312 1985
721
Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. 38
3965112 1985
722
Bilateral breast cancer and radiotherapy for asthma. 38
3966732 1985
723
Family history and bilateral primary breast cancer. 38
4016285 1985
724
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer. 38
6498774 1984
725
[Influence of family history, irradiation and anti-cancer drug (mitomycin C) on the occurrence of multiple primary neoplasms in breast carcinoma patients]. 38
6438367 1984
726
Hypophyseal tumor and gynecomastia preceding bilateral breast cancer development in a man. 38
6704924 1984
727
Bilateral breast cancer in northern Alberta: risk factors and survival patterns. 38
6322952 1984
728
[Bilateral breast cancer--an underestimated source of knowledge?]. 38
6717182 1984
729
[Bilateral breast cancer. A clinical problem]. 38
6093064 1984
730
Peutz-Jeghers syndrome. Association of duodenal and bilateral breast cancers in the same patient. 38
6321116 1984
731
Bilateral breast carcinoma. 38
6701380 1984
732
Breast cancer in 120 women under 35 years old. A 10-year community-wide survey. 38
6691629 1984
733
Second primary cancers of the breast: incidence and risk factors. 38
6691900 1984
734
[Bilateral breast carcinoma. Considerations on 11 treated cases]. 38
6320058 1983
735
Inconsistencies in breast carcinoma registration. An investigation of 855 cases reported to the Swedish Cancer Registry. 38
6310963 1983
736
Adjustment of the contralateral breast following breast reconstruction. 38
6673089 1983
737
Incidence of lobular carcinoma in bilateral breast cancer. 38
6293326 1982
738
Bilateral breast cancer in patients with initial stage I and II disease. 38
7104963 1982
739
Peutz-Jeghers syndrome and bilateral breast carcinoma. 38
7093914 1982
740
[The problem of bilateral breast cancer]. 38
7087729 1982
741
[The problem of multiple breast cancers (author's transl)]. 38
6276962 1982
742
Synchronous and metachronous carcinoma of the breast. 38
7054899 1982
743
[Role of xeromammography in the diagnosis of bilateral breast cancer]. 38
7186120 1982
744
Bilateral breast cancer in a Chinese male. 38
6274288 1981
745
The incidence of bilateral breast cancer: II. A proposed model for the analysis of coincidental tumours. 38
7248146 1981
746
Bilateral breast cancer: radiation therapy results and technical considerations. 38
7275710 1981
747
[Bilateral carcinoma of the breast]. 38
7242984 1981
748
Factors influencing survival in bilateral breast cancer. 38
7253654 1981
749
Familial bilateral breast cancer. 38
6265708 1981
750
Biological and histological characteristics of simultaneous bilateral breast cancer. 38
6107724 1980
751
Bilateral fat necrosis of the breast: report of a case. 38
6449133 1980
752
Managing the remaining breast. 38
7397652 1980
753
A family with Peutz-Jeghers syndrome and bilateral breast cancer. 38
7397644 1980
754
[Cystosarcoma phylloides of the breast and bilateral breast cancer. Case report]. 38
6256727 1980
755
Changing patterns of breast cancer. 38
229751 1979
756
The hormonal basis of breast cancer. 38
537626 1979
757
Investigation of a family suspected of being at high risk for cancer. 38
227555 1979
758
A thirty year study of breast cancer in a consecutive series of private patients. Is axillary nodal study a valuable index in prognosis? 38
686271 1978
759
Bilateral breast cancer. 38
356301 1978
760
Bilateral breast cancer and familial aggregations. 38
674108 1978
761
Metastasis to the vagina from carcinoma of the breast. 38
671397 1978
762
[A case of Peutz-Jeghers syndrome combined with bilateral breast cancer, an adenocarcinoma of the cervix and ovarian genital cord neoplasms with annular tubules]. 38
644282 1978
763
Familial breast cancer: report of a family pedigree. 38
629864 1978
764
[Clinico-morphological characteristics of bilateral breast cancer]. 38
678155 1978
765
[Therapeutic tactics in primary synchronous bilateral breast cancer]. 38
695417 1978
766
Thymus and breast cancer--plasma androgens, thymic pathology, and peripheral lymphocytes in myasthenia gravis. 38
144802 1977
767
Bilateral breast cancer associated with clomiphene. 38
73084 1977
768
Bilateral breast cancer: biopsy of the opposite breast. 38
907998 1977
769
Breast carcinoma following radiotherapy of metastatic Wilm's tumor. 38
198096 1977
770
Radiation-induced fibrosarcoma following treatment for breast cancer. 38
191947 1977
771
Simultaneous bilateral breast cancer. 38
852934 1977
772
[Bilateral breast cancer]. 38
846140 1977
773
Bilateral breast cancer-biopsy of contralateral breast. 38
918120 1977
774
Bilateral breast cancer what about the other breast? 38
1012550 1976
775
[Bilateral breast cancer (author's transl)]. 38
968380 1976
776
An evaluation of bilateral breast carcinoma. Simultaneous and sequential lesions. 38
1258467 1976
777
[Bilateral carcinoma of the breast]. 38
167326 1975
778
Non-simultaneous bilateral breast carcinoma. 38
4363178 1974
779
Bilateral breast cancer 10 years after an augmentation mammaplasty: case report. 38
4809558 1974
780
[The problem of bilateral breast cancer. Personal experience]. 38
4697313 1973
781
[Prognosis of bilateral breast cancer]. 38
4657996 1972
782
Bilateral breast cancer, clinical and pathological review. 38
5028480 1972
783
[Bilateral breast carcinoma among cases treated at the Institute of Oncology in Gliwice]. 38
5022268 1972
784
Bilateral breast cancer at the Johns Hopkins Hospital. A discussion of the dilemma of contralateral breast cancer. 38
5156944 1971
785
Sipple's syndrome (pheochromocytoma and thyroid carcinoma) with bilateral breast carcinoma. 38
4996803 1971
786
[Bilateral breast cancer]. 38
5574998 1971
787
[Bilateral breast cancer]. 38
5091037 1971
788
Bilateral breast cancer. 38
5574616 1971
789
Bilateral breast cancer. 38
5389668 1969
790
[Bilateral breast cancer. Simultaneous and recurrent secondary breast cancer]. 38
5387192 1969
791
[Therapeutic approach in bilateral breast cancer]. 38
5387184 1969
792
Bilateral breast cancer in relation to the menses. 38
5811574 1969